Analytic Investors’s Merck MRK Stock Holding History

Analytic Investors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$63.5M	Buy	1,066,096 +725,974	+213%	+$42.5M	0.71%	41
2016 Q2	$18.7M	Sell	340,122 -267,355	-44%	-$14.2M	0.22%	102
2016 Q1	$30.7M	Buy	607,477 +59,076	+11%	+$2.89M	0.37%	75
2015 Q4	$27.6M	Sell	548,401 -754,827	-58%	-$38.1M	0.35%	78
2015 Q3	$61.4M	Sell	1,303,228 -1,722,339	-57%	-$91.5M	0.82%	38
2015 Q2	$164M	Buy	3,025,567 +675,086	+29%	+$37.9M	2.31%	4
2015 Q1	$129M	Buy	2,350,481 +176,682	+8%	+$10M	1.76%	11
2014 Q4	$118M	Buy	2,173,799 +674,589	+45%	+$37.6M	1.67%	11
2014 Q3	$84.8M	Sell	1,499,210 -539,089	-26%	-$30.3M	1.21%	16
2014 Q2	$113M	Sell	2,038,299 -338,288	-14%	-$18.5M	1.82%	8
2014 Q1	$129M	Buy	2,376,587 +1,987,799	+511%	+$103M	1.96%	5
2013 Q4	$18.6M	Sell	388,788 -55,805	-13%	-$2.55M	0.31%	95
2013 Q3	$20.2M	Buy	444,593 +370,454	+500%	+$16.9M	0.33%	96
2013 Q2	$3.29M	Buy	+74,139	New	+$3.31M	0.05%	231

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Analytic Investors's MRK Position: Q3 2016 in Review

Analytic Investors increased its Merck (MRK) stake by 213% in Q3 2016, buying an estimated $42.5M and bringing the position to 1,066,096 shares worth $63.5M. The position accounts for 0.71% of the portfolio, ranked #41.

Analytic Investors first reported a position in MRK in Q2 2013 and has held it in 14 quarters since. The position peaked at $164M in Q2 2015. 1,814 funds tracked by Wall St. Rank hold MRK as of Q3 2016.

Analytic Investors held 1,066,096 shares of Merck worth $63.5M as of Q3 2016.
Analytic Investors bought 725,974 Merck shares in Q3 2016, an estimated $42.5M.
Merck made up 0.71% of Analytic Investors's portfolio in Q3 2016, its #41 holding.
Analytic Investors first reported a position in Merck in Q2 2013 and has held it in 14 quarters since.
Analytic Investors's Merck position peaked at $164M in Q2 2015.
1,814 funds tracked by Wall St. Rank held Merck as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.